Tickers

1. Composite Trajectory Verdict

For a capital-intensive logistics company that returns substantial cash to shareholders, the cash flow statement carries the most weight because it directly funds capital expenditures, debt service, dividends, and share repurchases.

Composite Trajectory: Deteriorating

All three financial statements show year-over-year deterioration in 2025 versus 2024. Revenue fell 2.6% to $88.7B, operating profit declined 7.1% to $7.9B, and net income dropped 3.6% to $5.6B (10-K 2025-12-31, Consolidated Statements of Operations). Operating cash flow fell 16.5% to $8.5B, well below the $10.1B generated in 2024 (10-K 2025-12-31, Statements of Consolidated Cash Flows). Total debt rose $2.8B to $24.1B while shareowners’ equity declined to $16.3B from $16.7B, increasing leverage (10-K 2025-12-31, Consolidated Balance Sheets). No statement shows an improving trend on a GAAP basis.

2. Red Flags

• Earnings–cash flow divergence: Net income fell only 3.6% ($5.572B vs $5.782B) but operating cash flow fell 16.5% ($8.450B vs $10.122B), driven by a $667M unfavorable working capital swing and higher incentive compensation payments (10-K 2025-12-31, Statements of Consolidated Cash Flows).
• Margin compression across segments: Consolidated operating margin contracted to 8.9% from 9.3%; U.S. Domestic margin fell to 6.6% from 7.2%; International margin fell to 15.5% from 17.8% (10-K 2025-12-31, MD&A).
• Rising leverage: Total debt increased to $24.1B from $21.3B while equity declined to $16.3B from $16.7B, pushing debt-to-equity to ~1.48x from ~1.27x (10-K 2025-12-31, Consolidated Balance Sheets).
• Persistent non-GAAP adjustments: Transformation strategy costs rose to $593M from $322M; goodwill and asset impairment charges rose to $182M from $108M; a $182M MD-11 fleet retirement charge was recorded in 2025 (10-K 2025-12-31, MD&A – Supplemental Information).
• Goodwill impairment risk: GFF ($877M) and HLD ($738M) reporting units show limited excess fair value over carrying value; an interim Q4 2025 test confirmed continued risk (10-K 2025-12-31, Note 7 – Goodwill and Intangible Assets).
• Pension underfunding: U.S. pension plans remain underfunded by $4.8B (projected benefit obligation $48.5B vs plan assets $43.7B) (10-K 2025-12-31, Note 5 – Funded Status).
• Receivables factoring introduced: $734M of receivables sold in 2025 with $491M outstanding at year-end, creating a new financing liability (10-K 2025-12-31, Note 2 – Revenue Recognition).
• Sale-leaseback gains boosting earnings: $362M gain on sale-leasebacks recorded in Other expenses, partially offsetting operating deterioration (10-K 2025-12-31, Note 4 – Sale-Leaseback Transactions).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Revenue declined for the first year in the three-year period, falling 2.6% to $88.7B from $91.1B (10-K 2025-12-31, Consolidated Statements of Operations). Operating profit dropped 7.1% to $7.9B, with operating margin compressing 40 basis points to 8.9%. Net income declined 3.6% to $5.6B, and diluted EPS fell to $6.56 from $6.75. Volume (average daily packages) fell 7.0% to 20.8M, partially offset by a 6.6% increase in revenue per piece to $14.50 (10-K 2025-12-31, MD&A – Highlights). All three segments saw operating profit declines in GAAP terms: U.S. Domestic -9.6%, International -10.0%, while SCS operating profit rose 14.6% but on a 17.0% revenue decline driven by the Coyote divestiture (10-K 2025-12-31, MD&A – Segment discussions). The three-year trend shows consecutive annual declines in operating profit ($9.1B → $8.5B → $7.9B) and net income ($6.7B → $5.8B → $5.6B).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Net cash from operating activities fell 16.5% to $8.45B from $10.12B, the lowest level in the three-year period (10-K 2025-12-31, Statements of Consolidated Cash Flows). The decline was driven by a $667M unfavorable change in working capital (vs a $33M favorable change in 2024), higher incentive compensation payments, and higher tax payments (10-K 2025-12-31, MD&A – Liquidity). Capital expenditures decreased to $3.69B from $3.91B, yielding free cash flow (operating cash flow minus capex) of approximately $4.8B, down from $6.2B. Dividends paid remained flat at $5.4B, while share repurchases doubled to $1.0B from $0.5B. Net cash used in financing activities improved to $4.1B from $6.9B due to higher debt issuance ($4.2B vs $2.8B), but the company relied on borrowing to fund shareholder returns while operating cash generation weakened.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total assets grew 4.3% to $73.1B from $70.1B, primarily from goodwill ($5.8B vs $4.3B) and intangible assets ($4.0B vs $3.1B) due to acquisitions (Frigo-Trans, AHG) (10-K 2025-12-31, Consolidated Balance Sheets). Total debt (current + long-term) rose 13.4% to $24.1B from $21.3B, while cash and equivalents dipped to $5.9B from $6.1B. Shareowners’ equity fell to $16.3B from $16.7B, driven by a $731M decline in retained earnings (dividends exceeded net income) and a $101M increase in accumulated other comprehensive loss. Pension and postretirement obligations decreased modestly to $6.6B from $6.9B. The debt-to-equity ratio increased materially, and the current portion of long-term debt fell to $608M from $1.8B due to refinancing, but near-term maturities include $500M of senior notes due in 2026 (10-K 2025-12-31, MD&A – Liquidity).

6. Data Gaps

• Quarterly GAAP trends for 2025 and Q1 2026 (the 10-Q filings were listed but not provided in the document set).
• Segment-level quarterly revenue, operating profit, and margin to assess intra-year trajectory.
• Free cash flow after dividends (not explicitly disclosed; requires netting dividends from operating cash flow minus capex).
• Detailed breakdown of transformation strategy costs by segment for 2024–2025 to assess run-rate.
• Projected 2026 capital expenditures ($3.0B guided) vs actual quarterly spend to date.
• Interest coverage ratio (operating income / interest expense) for 2025 vs prior years (interest expense rose to $1.017B from $866M).
• Accounts receivable aging and allowance trends beyond the $44M increase disclosed.